The 2024 CDC Yellow Book: Health Information for International Travel provides additional details for immunocompromised travelers.175 The Yellow Book states that HSCT recipients should ideally delay travel for at least 2 years after transplant, noting...
With the American Society of Clinical Oncology (ASCO) moving to a virtual platform for its 2020 Annual Meeting, Janssen Oncology remains determined in our efforts to champion science for patients. Thank you for visiting to check out our news from ASCO2020, and to learn more about how we ...
And I would encourage your podcast listeners to access the lecture in ASCO's Meeting Library if they haven't yet had a chance to hear Dr. Kunz’s wonderful lecture. We were really happy this year because the attendance hit a new record. We had over 5,000 people attend either in person...
Per the 2024 CDC Yellow Book: Health Information for International Travel information for immunocompromised travelers, travel vaccinations should in general be delayed until at least 3 months from last chemotherapy exposure and with disease in remission for patients with solid tumors.175 Patients with ac...
Patient was referred for high dose chemotherapy and autologous stem cell therapy. The latter could not be achieved. The patient had a relapse 3 months later and succumbed to the disease.doi:10.1002/cncr.29581Carrie PrintzJohn Wiley & Sons, LtdCancer...
Meeting Your Growing Needs Since 1925 LANDSCAPE DESIGN SERVICES Fun Fact: Wasco Nursery is Celebrating it’s 100th Anniversary Over 10 Acres of the best quality trees, shrubs, perennials, annuals, herbs & vegetables in the area. Come visit and see for yourself why we have been consistently ...
根据2024年《CDC黄皮书:国际旅行健康信息》中关于免疫抑制旅行者的内容,旅行疫苗接种通常应在最后一次化疗后至少3个月并且疾病处于缓和期进行。175 对于处于观察阶段的活跃未治疗实体恶性肿瘤患者,在考虑接种活病毒疫苗之前,应与其医疗保健提供者讨论旅行时间和免疫抑制程度。某些化疗和靶向药物的免疫抑制作用较小,包括已证...
恒瑞医药自主原研的PD-1抑制剂卡瑞利珠单抗强势亮相2021ASCO。自问世起便备受行业认可并多次登上国际舞台,今年ASCO年会期间,卡瑞利珠单抗一共入选38项研究(3项oral、14项e-poster、21项online abstract)【1】,横跨乳腺癌、消化道肿瘤、肺癌、胰腺癌等11个癌种,展现出强劲实力。今年ASCO恒瑞医药共有64项研究入选,卡...
62,67,71,75,112 目前最新的建议是,已接种新冠疫苗的个体应接种至少一剂更新的2023-2024年新冠疫苗(任何经授权的抗原)。17 在治疗周期中,没有推荐的最佳接种时间。对于接受已知会削弱疫苗反应的治疗的患者,提供者应强烈推荐在间隔2个月后接种额外的疫苗剂次。对于最近患有新冠感染的个体,建议推迟接种疫苗2-3个...
In this issue, the SWOG S1826, INDIGO, ADAURA, and PROSPECT trials, presented at this year's American Society of Clinical Oncology annual meeting, focused on the impact that targeted therapies can have on progression‐free and disease‐free survival. In addition, more patients with advanced ...